Funding · Company
Genesis Therapeutics, Inc.
Burlingame, CABiotech & Pharma
Genesis Therapeutics, Inc. of Burlingame, CA has disclosed $248M across 2 Form D offerings filed with the SEC between Dec 23, 2022 and Aug 25, 2023.
$248M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBurlingame, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001775819Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →